SPL

Results: 1109



#Item
351

PDF Document

Add to Reading List

Source URL: www.spl.ch

- Date: 2006-04-11 09:53:53
    352AMS INTERLINE NETWORK SCHEDULE S15 (29 March 2015 to 24 OctoberVia SPL FLT.# NCA Interline Network LTL Service Connecting to:

    AMS INTERLINE NETWORK SCHEDULE S15 (29 March 2015 to 24 OctoberVia SPL FLT.# NCA Interline Network LTL Service Connecting to:

    Add to Reading List

    Source URL: www.nca.aero

    Language: English - Date: 2015-03-13 03:34:44
      353VivaGel® condom approved for sale with launch imminent Melbourne, Australia; 2 October 2014: Starpharma (ASX:SPL, OTCQX:SPHRY) today announced the inclusion of the VivaGel® condom in the Australian Register of Therapeu

      VivaGel® condom approved for sale with launch imminent Melbourne, Australia; 2 October 2014: Starpharma (ASX:SPL, OTCQX:SPHRY) today announced the inclusion of the VivaGel® condom in the Australian Register of Therapeu

      Add to Reading List

      Source URL: www.starpharma.com

      Language: English - Date: 2014-10-06 22:45:28
      354Quarterly Cashflow Report Melbourne, Australia; 31 October 2014: Starpharma Holdings Ltd (ASX: SPL, OTCQX: SPHRY) today released its Appendix 4C – Quarterly Cashflow report for the period ended 30 SeptemberThe

      Quarterly Cashflow Report Melbourne, Australia; 31 October 2014: Starpharma Holdings Ltd (ASX: SPL, OTCQX: SPHRY) today released its Appendix 4C – Quarterly Cashflow report for the period ended 30 SeptemberThe

      Add to Reading List

      Source URL: www.starpharma.com

      Language: English - Date: 2014-11-02 19:41:18
      355Quarterly Cashflow Report Melbourne, Australia; 28 January 2015: Starpharma Holdings Ltd (ASX: SPL, OTCQX: SPHRY) today released its Appendix 4C – Quarterly Cashflow report for the period ended 31 DecemberThe c

      Quarterly Cashflow Report Melbourne, Australia; 28 January 2015: Starpharma Holdings Ltd (ASX: SPL, OTCQX: SPHRY) today released its Appendix 4C – Quarterly Cashflow report for the period ended 31 DecemberThe c

      Add to Reading List

      Source URL: www.starpharma.com

      Language: English - Date: 2015-01-27 22:31:27
      356VivaGel® condom now available in Australian stores Melbourne, Australia; 29 October 2014: Starpharma Holdings Ltd (ASX: SPL, OTCQX: SPHRY) is pleased to announce that the Company has been notified by its commercial part

      VivaGel® condom now available in Australian stores Melbourne, Australia; 29 October 2014: Starpharma Holdings Ltd (ASX: SPL, OTCQX: SPHRY) is pleased to announce that the Company has been notified by its commercial part

      Add to Reading List

      Source URL: www.starpharma.com

      Language: English - Date: 2014-11-02 19:41:18
      357Starpharma receives $4.7M R&D tax incentive Melbourne, Australia; 11 March 2014: Starpharma (ASX: SPL, OTCQX: SPHRY) today announced it has received the anticipated $4.7M of R&D tax incentive relating to FY13 expenditure

      Starpharma receives $4.7M R&D tax incentive Melbourne, Australia; 11 March 2014: Starpharma (ASX: SPL, OTCQX: SPHRY) today announced it has received the anticipated $4.7M of R&D tax incentive relating to FY13 expenditure

      Add to Reading List

      Source URL: www.starpharma.com

      Language: English - Date: 2014-03-10 23:11:49
      358Healthcare & Biotech Update - Backing De-risked Biotech Advantage to gold standard, Believable managers, Cash Flow January 2015 Ranking of covered companies: Starpharma (SPL) - Buy Medical Developments (MVP) - Buy

      Healthcare & Biotech Update - Backing De-risked Biotech Advantage to gold standard, Believable managers, Cash Flow January 2015 Ranking of covered companies: Starpharma (SPL) - Buy Medical Developments (MVP) - Buy

      Add to Reading List

      Source URL: www.starpharma.com

      Language: English - Date: 2015-03-30 23:17:37
      359Starpharma commences Dendrimer-Docetaxel clinical trial Melbourne, Australia; 23 January 2014: Starpharma (ASX: SPL, OTCQX: SPHRY) today announced that it has received the necessary approvals to commence a phase 1 human

      Starpharma commences Dendrimer-Docetaxel clinical trial Melbourne, Australia; 23 January 2014: Starpharma (ASX: SPL, OTCQX: SPHRY) today announced that it has received the necessary approvals to commence a phase 1 human

      Add to Reading List

      Source URL: www.starpharma.com

      Language: English - Date: 2014-01-23 22:49:58
      360Starpharma Interim Report and Half-year Financial Results Melbourne, Australia; 16 February 2015: Starpharma Holdings Ltd (ASX: SPL, OTCQX: SPHRY) today released its interim report and financial results for the half-year

      Starpharma Interim Report and Half-year Financial Results Melbourne, Australia; 16 February 2015: Starpharma Holdings Ltd (ASX: SPL, OTCQX: SPHRY) today released its interim report and financial results for the half-year

      Add to Reading List

      Source URL: www.starpharma.com

      Language: English - Date: 2015-02-15 20:27:50